Development and Validation of Novel Signature to Predict Overall Survival in "Driver-Gene-Negative" Lung Adenocarcinoma (LUAD): Results of a Multicenter Study
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-2545
Full Text
Open PDFAbstract
Available in full text
Date
November 2, 2018
Authors
Publisher
American Association for Cancer Research (AACR)